Vernier P, Moret F, Callier S, Snapyan M, Wersinger C, Sidhu A (2004) The degeneration of dopamine neurons in Parkinson’s disease: insights from embryology and evolution of the mesostriatocortical system. Ann N Y Acad Sci 1035(1):231–249

Article  PubMed  CAS  Google Scholar 

Onyango IG (2008) Mitochondrial dysfunction and oxidative stress in Parkinson’s disease. Neurochem Res 33:589–597

Article  PubMed  CAS  Google Scholar 

Kaur K, Gill JS, Bansal PK, Deshmukh R (2017) Neuroinflammation-a major cause for striatal dopaminergic degeneration in Parkinson’s disease. J Neurol Sci 15(381):308–314

Article  Google Scholar 

Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson’s disease. Neuron 90(4):675–691

Article  PubMed  CAS  Google Scholar 

Morgan AJ, Platt FM, Lloyd-Evans E, Galione A (2011) Molecular mechanisms of endolysosomal Ca2+ signalling in health and disease. Biochemical Journal 439(3):349–378

Article  PubMed  CAS  Google Scholar 

Glinka YY, Youdim MB (1995) Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur J Pharmacol Environ Toxicol Pharm 292(3–4):329–332

Article  CAS  Google Scholar 

Elyasi L, Jahanshahi M, Jameie SB, Hamid Abadi HG, Nikmahzar E, Khalili M, Jameie M, Jameie M (2021) 6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson’s disease suppressed by pretreatment with hesperidin through activating L-type calcium channels. J Basic Clin Physiol Pharmacol 32(2):11–17

Article  CAS  Google Scholar 

Marques NF, Massari CM, Tasca CI (2019) Guanosine protects striatal slices against 6-OHDA-induced oxidative damage, mitochondrial dysfunction, and ATP depletion. Neurotox Res 35(2):475–483

Article  PubMed  CAS  Google Scholar 

Franco-Iborra S, Vila M, Perier C (2018) Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson’s disease and Huntington’s disease. Front Neurosci 23(12):342

Article  Google Scholar 

Gustafsson ÅB, Dorn GW (2019) Evolving and expanding the roles of mitophagy as a homeostatic and pathogenic process. Physiol Rev 99(1):853–892

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ashrafi G, Schwarz TL (2013) The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ 20(1):31–42

Article  PubMed  CAS  Google Scholar 

Wang S, Long H, Hou L, Feng B, Ma Z, Wu Y, Zeng Y, Cai J, Zhang DW, Zhao G (2023) The mitophagy pathway and its implications in human diseases. Signal Transduct Target Ther 8(1):304

Article  PubMed  PubMed Central  Google Scholar 

Moradi Vastegani S, Nasrolahi A, Ghaderi S, Belali R, Rashno M, Farzaneh M, Khoshnam SE (2023) Mitochondrial dysfunction and Parkinson’s disease: pathogenesis and therapeutic strategies. Neurochem Res 48(8):2285–2308

Article  PubMed  CAS  Google Scholar 

Pinton P, Rizzuto R (2006) Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum. Cell Death Differ 13(8):1409–1418

Article  PubMed  CAS  Google Scholar 

Ouyang M, Shen X (2006) Critical role of ASK1 in the 6‐hydroxydopamine‐induced apoptosis in human neuroblastoma SH‐SY5Y cells. J Neurochem 97(1):234–244

Article  PubMed  CAS  Google Scholar 

Biondi RM, Nebreda AR (2003) Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochemical Journal 372(1):1–3

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wright DC, Geiger PC, Han DH, Jones TE, Holloszy JO (2007) Calcium increases peroxisome proliferator-activated receptor γ coactivator-1α and mitochondrial biogenesis by a pathway leading to p38 mitogen-activated protein kinase activation. J Biol Chem 282(26):18793–18799

Article  PubMed  CAS  Google Scholar 

Hwang CJ, Kim YE, Son DJ, Park MH, Choi DY, Park PH, Hellström M, Han SB, Oh KW, Park EK, Hong JT (2017) Parkin deficiency exacerbates ethanol-induced dopaminergic neurodegeneration by P38 pathway-dependent inhibition of autophagy and mitochondrial function. Redox Biol 1(11):456–468

Article  Google Scholar 

Wang H, Song P, Du L, Tian W, Yue W, Liu M, Li D, Wang B, Zhu Y, Cao C, Zhou J (2011) Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson’s disease. J Biol Chem 286(13):11649–11658

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tang J, Hu Z, Tan J, Yang S, Zeng L (2016) Parkin protects against oxygen‐glucose deprivation/reperfusion insult by promoting Drp1 degradation. Oxid Med Cell Longev 1:8474303

Article  Google Scholar 

Wang W, Nguyen LT, Burlak C, Chegini F, Guo F, Chataway T, Ju S, Fisher OS, Miller DW, Datta D, Wu F (2016) Caspase-1 causes truncation and aggregation of the Parkinson’s disease-associated protein α-synuclein. Proc Natl Acad Sci 113(34):9587–9592

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang DB, Garden GA, Kinoshita C, Wyles C, Babazadeh N, Sopher B, Kinoshita Y, Morrison RS (2013) Declines in Drp1 and parkin expression underlie DNA damage-induced changes in mitochondrial length and neuronal death. J Neurosci 33(4):1357–1365

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhou L, Zhang Q, Zhang P, Sun L, Peng C, Yuan Z, Cheng J (2017) c-Abl-mediated Drp1 phosphorylation promotes oxidative stress-induced mitochondrial fragmentation and neuronal cell death. Cell Death Dis 8(10):e3117

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gui C, Ren Y, Chen J, Wu X, Mao K, Li H, Yu H, Zou F, Li W (2020) p38 MAPK-DRP1 signalling is involved in mitochondrial dysfunction and cell death in mutant A53T α-synuclein model of Parkinson’s disease. Toxicol Appl Pharmacol 1(388):114874

Article  Google Scholar 

Chen J, Ren Y, Gui C, Zhao M, Wu X, Mao K, Li W, Zou F (2018) Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson’s disease. Cell Death Dis 9(6):700

Article  PubMed  PubMed Central  Google Scholar 

Ferre S, Quiroz C, Woods AS, Cunha R, Popoli P, Ciruela F, Lluis C, Franco R, Azdad K, Schiffmann SN (2008) An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Curr Pharm Des 14(15):1468–1474

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ciruela F, Casadó V, Rodrigues RJ, Luján R, Burgueno J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, Cortés A (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1–A2A receptor heteromers. J Neurosci 26(7):2080–2087

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gonçalves FQ, Matheus FC, Silva HB, Real JI, Rial D, Rodrigues RJ, Oses JP, Silva AC, Gonçalves N, Prediger RD, Tomé ÂR (2023) Increased ATP release and higher impact of adenosine A2A receptors on corticostriatal plasticity in a rat model of presymptomatic Parkinson’s disease. Mol Neurobiol 60(3):1659–1674

Article  PubMed  Google Scholar 

Nunes AC, Carmo M, Behrenswerth A, Canas PM, Agostinho P, Cunha RA (2024) Adenosine A2A receptor blockade provides more effective benefits at the onset rather than after overt neurodegeneration in a rat model of Parkinson’s disease. Int J Mol Sci 25(9):4903

Article  PubMed  PubMed Central  CAS  Google Scholar 

Silva CG, Porciúncula LO, Canas PM, Oliveira CR, Cunha RA (2007) Blockade of adenosine A2A receptors prevents staurosporine-induced apoptosis of rat hippocampal neurons. Neurobiol Dis 27(2):182–189

Article  PubMed  CAS